Drug intelligence / Profile preview

zidovudine monophosphate

Development stage
Preclinical
Lead developer
ViiV Healthcare
Modality
Small Molecules
01

Overview

Zidovudine monophosphate is the phosphorylated metabolite of zidovudine (AZT), a nucleoside analog reverse transcriptase inhibitor (NRTI). It is not itself an approved pharmaceutical drug, but rather an intermediate formed during the intracellular activation of zidovudine. Zidovudine is first phosphorylated by thymidine kinase to form zidovudine monophosphate, which is then further phosphorylated to its active triphosphate form. The active triphosphate inhibits HIV reverse transcriptase by acting as a chain terminator during viral DNA synthesis, thereby blocking HIV replication[1][4][6]. Zidovudine monophosphate has been studied primarily in experimental and research contexts.

Other names
3'-Azido-2',3'-deoxythymidine 5'-monophosphate3'-Azido-3'-deoxythymidine 5'-phosphateZidovudine 5'-monophosphateAZT-MPazidothymidine monophosphateZdv 5'-monophosphate
02

Targets

Human immunodeficiency virus type 1 reverse transcriptase

Beyond the preview

Go deeper on zidovudine monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zidovudine monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call